Research and Markets (http://www.researchandmarkets.com/research/lbvxd2/countryfocus) has announced the addition of the "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Germany" report to their offering.

The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Germany. It identifies the key trends in the country's healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by a team of industry experts.

Germany's increasingly elderly population and its associated disease burden are key drivers of its pharmaceutical market. In 2013, the elderly accounted for 27.1% of the total population, expected to increase at Compound Annual Growth Rate (CAGR) of 1.2% to 29.5% in 2020.

In 2008, healthcare expenditure as percentage of Gross Domestic Product (GDP) amounted to 10.7%, which increased to an estimated 11.5% in 2013. In 2011, the government initiated a new plan - Arzneimittelmarkt-Neuordnungsgesetz (AMNOG) - to curb healthcare expenditure.

The pharmaceuticals market was worth $54.7 billion in 2008 and is projected to have reached a value of approximately $65 billion by 2020 at a CAGR of 1.4%. The German medical device market was valued at $18.9 billion in 2008 and is projected to grow at a CAGR of 5.1% to reach $34.4 billion in 2020.

These positive growth trends can be primarily attributed to

  • The rising prevalence of chronic disease
  • Universal health coverage
  • Well established and centralized regulatory procedure

Scope

  • An overview of the pharmaceuticals and medical device markets, consisting of market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market - Novartis, Pfizer, Teva Pharmaceutical, Sanofi and Roche - and profiles and SWOT analyses of the major players in the medical device market - Medtronic, Siemens Healthcare, F. Hoffmann-La Roche, Philips Healthcare and GE Abbott Laboratories
  • Insightful review of the reimbursement and regulatory landscape, with analysis covering details of the country's healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
  • Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in the healthcare market

Key Topics Covered:

1 Tables & Figures

2 Introduction

3 Overview of Pharmaceutical and Medical Device Market

4 Market Access

5 Country Analysis

6 Opportunities and Challenges

7 Appendix

For more information visit http://www.researchandmarkets.com/research/lbvxd2/countryfocus

Research and MarketsLaura Wood, Senior Managerpress@researchandmarkets.comFor E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT Office Hours Call +353-1-416-8900U.S. Fax: 646-607-1907Fax (outside U.S.): +353-1-481-1716Sector: Pharmaceuticals